Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China · Delayed Price · Currency is CNY 18.06
+0.81 (4.70%)
Jul 10, 2026, 3:00 PM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 9.34 billion as of July 10, 2026. Its market cap has increased by 3.37% in one year.
Market Cap
9.34B
Enterprise Value
7.40B
Revenue
1.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
18.06
Market Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 9.34B, a decrease of -72.65%. That is a compound annual growth rate of -24.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 9.34B | 17.26% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
| Nov 15, 2021 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GemPharmatech | 9.91B |
| Hualan Biological Vaccine | 9.77B |
| Chengdu Easton Biopharmaceuticals | 8.98B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.94B |
| Chongqing Genrix Biopharmaceutical | 8.77B |
| Pacific Shuanglin Bio-pharmacy | 8.57B |
| Sino Biological,Inc. | 8.52B |
| Aurisco Pharmaceutical | 8.15B |